Mpm Bioimpact LLC: holdings and changes
Number 25 of the top 100 funds by copy return. Mpm Bioimpact LLC reported 36 US stocks worth $1.3B for the quarter ending 2026-09-30 and changed 9 new, 7 added, 9 trimmed and 10 sold since 2026-06-30.
Copy return, 4 quarters+59.0%
US 500, same time+14.5%
Size$1.3B
Stocks36
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| CULLINAN ONCOL Cullinan Oncology INC | 11.49% | $149M | 9,721,081 | |
| AKTS Aktis Oncology INC | 7.25% | $94M | 4,835,872 | |
| TVTX Travere Therapeutics INC | TRIM -3% | 4.93% | $64M | 1,088,363 |
| EWTX Edgewise Therapeutics INC | 4.93% | $64M | 1,575,987 | |
| DYN Dyne Therapeutics INC | ADD +67% | 3.98% | $52M | 3,208,146 |
| CORT Corcept Therapeutics INC | TRIM -45% | 3.74% | $49M | 422,000 |
| RLAY Relay Therapeutics INC | 3.29% | $43M | 2,369,578 | |
| TRVI Trevi Therapeutics | TRIM -3% | 3.28% | $43M | 2,978,906 |
| IOVA Iovance Biotherapeutics INC | BUY | 3.24% | $42M | 2,835,734 |
| LIQUIDIA TECHN Liquidia Technologies INC | TRIM -3% | 3.13% | $41M | 1,342,713 |
| NTRA Natera INC | 2.88% | $37M | 90,585 | |
| URGN Urogen Pharma LTD | 2.85% | $37M | 909,691 | |
| IMCR Immunocore Holdings Limited | BUY | 2.81% | $36M | 1,203,289 |
| DBVT Dbv Technologies S A | TRIM -17% | 2.76% | $36M | 3,044,659 |
| TSHA Taysha Gene Therapies INC Com Shs | ADD +61% | 2.72% | $35M | 7,262,959 |
| ABVX Abivax Sa-Adr | 2.50% | $32M | 328,379 | |
| VIR Vir Biotechnology INC | BUY | 2.42% | $31M | 2,809,711 |
| ANL Adlai Nortye LTD | 2.41% | $31M | 1,956,618 | |
| VSTM Verastem INC | BUY | 2.39% | $31M | 3,851,604 |
| QURE Uniqure Nv | 2.23% | $29M | 1,201,413 | |
| ODTX Odyssey Therapeutics, INC. | BUY | 2.20% | $29M | 1,289,091 |
| TARS Tarsus Pharmaceuticals INC | ADD +10% | 2.13% | $28M | 352,676 |
| PVLA Palvella Therapeutics INC Ne | TRIM -3% | 2.10% | $27M | 197,633 |
| ACRS Aclaris Therapeutics INC | ADD +397% | 2.10% | $27M | 5,178,127 |
| ORKA Oruka Therapeutics INC | BUY | 1.92% | $25M | 300,000 |
| ORIC Oric Pharmaceuticals INC | TRIM -3% | 1.89% | $24M | 1,821,951 |
| STOK Stoke Therapeutics INC | ADD +28% | 1.85% | $24M | 925,133 |
| BLTE Belite Bio INC | 1.74% | $23M | 133,387 | |
| NGNE Neurogene INC Com | BUY | 1.65% | $22M | 771,839 |
| ZURA Zura Bio LTD | 1.42% | $18M | 4,449,671 | |
| ANNX Annexon INC | ADD +21% | 1.40% | $18M | 4,290,616 |
| GLUE Monte Rosa Therapeutics INC | TRIM -3% | 1.03% | $13M | 1,125,216 |
| BIOA Bioage Labs INC | ADD +11% | 1.01% | $13M | 1,856,748 |
| CRBP Corbus Pharmaceuticals Hldgs | BUY | 0.88% | $11M | 1,667,272 |
| DRUG Bright Minds Biosciences INC | TRIM -3% | 0.75% | $10M | 195,669 |
| TRAX First Tracks Biotherapeutics | BUY | 0.69% | $9M | 254,374 |
| RVMD Revolution Medicines INC | SELL | 0% | was $92M | 0 |
| ALMS Alumis INC | SELL | 0% | was $57M | 0 |
| RARE Ultragenyx Pharmaceutical In | SELL | 0% | was $47M | 0 |
| DNTH Dianthus Therapeutics INC | SELL | 0% | was $41M | 0 |
| MLTX Moonlake Immunot | SELL | 0% | was $31M | 0 |
| SNDX Syndax Pharmaceuticals INC | SELL | 0% | was $29M | 0 |
| FORTE BIOSCIEN Forte Bioscience INC | SELL | 0% | was $21M | 0 |
| TRDA Entrada Therapeutics, INC. | SELL | 0% | was $9M | 0 |
| CNTX Context Therapeutics INC | SELL | 0% | was $700k | 0 |
| HOWL Werewolf Therapeutics INC | SELL | 0% | was $0k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-03-31 → 2023-06-30 | +13.3% | +8.3% |
| 2023-12-31 → 2024-03-31 | +20.2% | +10.0% |
| 2024-03-31 → 2024-06-30 | -5.6% | +4.0% |
| 2024-06-30 → 2024-09-30 | +2.5% | +5.4% |
| 2024-09-30 → 2024-12-31 | -11.5% | +2.1% |
| 2024-12-31 → 2025-03-31 | -19.7% | -4.6% |
| 2025-03-31 → 2025-06-30 | +1.6% | +10.5% |
| 2025-06-30 → 2025-09-30 | +19.4% | +7.8% |
| 2025-09-30 → 2025-12-31 | +39.0% | +2.4% |
| 2025-12-31 → 2026-03-31 | +6.7% | -4.6% |
| 2026-03-31 → 2026-06-30 | +32.2% | +14.8% |
| 2026-06-30 → 2026-09-30 | -18.8% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP